Afshin Dowlati, MD
Schedule an Appointment
Biography
- Lucile and Robert H Gries Endowed Director, Center for Cancer Drug Development, University Hospitals
- Director, Thoracic Oncology Program, UH Seidman Cancer Center
- Director, Thoracic Oncology, UH Cleveland Medical Center
- Director, Phase I Drug Development Program, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Expertise
- Experimental Therapeutics
- Hematology/Oncology
- Lung Cancer
- Phase I Clinical Trials
- Thoracic Cancer
Languages Spoken
English, French, Farsi
Office Locations
Patient Experience Reviews
4.8 out of 5
82 Ratings
Patient Comments (32)
Reviewed On 2/1/2023
Sincere, with good clarity of medical issues, while providing comfort.
Reviewed On 2/1/2023
Excellent care and compassion
Reviewed On 2/1/2023
Grateful for a positive appointment.
Reviewed On 2/1/2023
Excellent interaction with this physician that I saw for additional opinions regarding treatment options.
Reviewed On 2/1/2023
Always professional, caring & thorough
Reviewed On 2/1/2023
I believe he is a good oncology doctor
Reviewed On 1/1/2023
My first visit with Dr Dowalti -seems knowledgeable and informed.
Reviewed On 12/1/2022
As a cancer patient I cannot imagine a better Doctor than Dr Dowlati.
Reviewed On 12/1/2022
Dr Dowlati was instrumental in discovering a second, primary cancer. Thank you for your excellent care!
Reviewed On 11/1/2022
Each visit with Dr D. Is absolutely amazing! He takes His time to explain my medical condition and the steps his team is taking to give me the best possible care. His bedside manner is wonderful. He even took the time to call me when he said he would. HE called. Not his secretary or nurse. HIM! He's a busy researcher and for him to take the time to call made me feel like I meant something.
Reviewed On 11/1/2022
I am well pleased with everyone I have had contact with and I would recommend them to all my friends and family. It is a pleasure to be around caring and passionate people. Thank You.
Reviewed On 11/1/2022
Explained health problems very clearly
Reviewed On 11/1/2022
I feel that the level of my care is excellent
Reviewed On 10/1/2022
Dr. Dowlati is an extraordinary Oncologist, with an excellent assistant and other first rate team members. ***
Reviewed On 10/1/2022
Good!
Reviewed On 10/1/2022
The visit was very helpful .
Reviewed On 9/2/2022
I could not be happier with the care I have received or the outcome I've experienced.
Reviewed On 9/2/2022
Very good experience
Reviewed On 9/2/2022
I changed from *** to Dr Dowlati because of his excellent care.
Reviewed On 9/2/2022
*** He was very thorough when reviewing my medical history and took his time explaining his opinion about further treatment. It was clear that Dr. Dowlati cared about me even though I am not actually his patient. I left my appointment feeling so much more confident about my treatment decision because of him!
Reviewed On 8/1/2022
This doctor is A+ and is providing me excellent healthcare. He is caring and very meticulous,
Reviewed On 7/1/2022
I have ***. A type of cancer that is fatal within 2 years for the overwhelming majority for those that contract it. With Dr Dowlati and his teams effort, expertise, and course of care I now feel better, healthier and stronger than I have for years! I also may realize the potential to live well beyond that 2 year mark! I am not just surviving but I am thrive 12 months in from diagnoses and THAT is the miracle of science when pursued and administered by dedicated and talented medical professionals. Dr. Dowlati's attention to the mental and emotional aspect of cancer care and treatment was also vital and incredibly beneficial. Thanks to all!!
Reviewed On 6/1/2022
Dr Dowlati's performance has exceeded my expectations. I feel unafraid of my situation and that is due to how he approaches things. He has an appealing, reassuring manner. How a physician makes you feel is almost as important as their clinical expertise. I'm so thankful for him.
Reviewed On 6/1/2022
My provider has consistently shown the highest degree of care, understanding, and professionalism throughout my cancer treatment.
Reviewed On 6/1/2022
He's patient and always is happy to answer my questions in a kind way.
Reviewed On 6/1/2022
Doctor always patient centric, coupled with his expertise. Reassuring, yet pragmatic.
Reviewed On 5/1/2022
Always exceptional treatment from Dr Dowlati and everyone who works with him.
Reviewed On 5/1/2022
Dr. Dowlati was very caring and compassionate and honored my wishes to be totally honest with my prognosis.
Reviewed On 5/1/2022
I have confidence in this provider and I feel I'm in the best hands possible
Reviewed On 5/1/2022
Excellent experience
Reviewed On 5/1/2022
Always attentive to my needs. Well balanced with his views on my condition, positive and sensitive which I very much appreciate.
Reviewed On 4/1/2022
*** Under his care I have made what I would describe as a full recovery. I understand that this cancer is one of the types deemed "incurable". However, I am confident in Dr Dowlati's care plans, advice, and his expertise, and though he has fully communicated the grave nature of the cancer I have I also believe that I can attain as much quality and quantity of life as is reasonable to expect. I say this because I now feel better than I have in the past several years leading up to my diagnosis. I attribute this to Dr Dowlati and his teams outstanding care, knowledge and medical abilities. I consider myself blessed to have access to the quality of care available at the UH Seidman Cancer Center.
Certifications & Memberships
- Medical Oncology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1998 - 2000)
Fellowship | Hematology/Oncology
Hematology/Oncology - University Hospitals Of Cleveland (1996 - 1998)
Internship | Internal Medicine
Internal Medicine - Universite De Liege Faculte De Medecine (1992 - 1996)
Medical Education
Universite De Liege Faculte De Medecine (1992)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Afshin Dowlati did not disclose any Outside Relationships with Industry.